Site search
2991 results for '' found
https://app.prompt.org.au/download/25002?code=21b43862b13b43be1e58b090e313aea4
https://app.prompt.org.au/download/269822?code=e74430cb-5bc3-4cd3-8bc5-096fe40caa3c
https://app.prompt.org.au/download/269823?code=bbebd9c7-cd97-45aa-939d-b50b0f524826
Bone Marrow Transplant (BMT) Clinic
/services/bone-marrow-transplant-bmt-clinic
MPN Clinic - Myeloproliferative Neoplasms
/services/mpn-clinic-myeloproliferative-neoplasms
Lymphoma/CAR-T Clinic
/services/lymphoma-car-t-clinic
Bayside_Health_Alfred_GP_News_-_September_2026.pdf
A Randomized, Phase 2/3, Open-Label Study to Investigate the Efficacy and Safety of RP2 in Combination with Nivolumab versus Ipilimumab in Combination with Nivolumab in Immune Checkpoint Inhibitor-Naï
A Randomized, Phase 2/3, Open-Label Study to Investigate the Efficacy and Safety of RP2 in Combination with Nivolumab versus Ipilimumab in Combination with Nivolumab in Immune Checkpoint Inhibitor-Naï
/
A Randomized, Phase 3, Open-label Study of Neoadjuvant Darovasertib in Subjects with Primary Non-metastatic Uveal Melanoma (NCT07015190)
A Randomized, Phase 3, Open-label Study of Neoadjuvant Darovasertib in Subjects with Primary Non-metastatic Uveal Melanoma (NCT07015190)
/
A Phase 1a/1b Randomized, Double-Blind, Placebo-Controlled, 3-Part Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Subcutaneous Doses of TRB-061 in Healt
A Phase 1a/1b Randomized, Double-Blind, Placebo-Controlled, 3-Part Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Subcutaneous Doses of TRB-061 in Healt
/